Actos News

Baum Hedlund Files Federal Actos Bladder Cancer Lawsuit
on Behalf of Virginia Couple
Monday, March 26, 2012

Baum, Hedlund, Aristei & Goldman filed an Actos bladder cancer lawsuit on March 21, 2012 against Japanese-based Takeda Pharmaceuticals and its subsidiaries and Eli Lilly and Company, on behalf of a Virginia man and his wife, alleging that Actos caused his bladder cancer.

Timothy Plaugher and his wife Peggy Ann Plaugher are suing Takeda for the injuries Mr. Plaugher suffered as a result of taking the diabetes medication Actos, an “unreasonably dangerous and defective drug” according to Mr. Plaugher’s Actos lawsuit. Mr. Plaugher claims that he developed bladder cancer after using the prescription drug to treat his Type-2 diabetes. The suit is seeking compensatory damages on behalf of Mr. and Mrs. Plaugher.

Takeda Pharmaceuticals knew or should have known that Actos use in humans increases the risk of developing bladder cancer, according to the complaint. The suit also alleges that for over a decade and to date, Takeda hid its knowledge that Actos was linked to a dangerous risk of bladder cancer and failed to completely disclose pre-clinical scientific studies that included animal evidence supporting this alarming connection.